adenoid cystic carcinoma
Showing 1 - 25 of 9,430
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in United States
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
-
San Francisco, California
- +5 more
Nov 1, 2023
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Adenoid Cystic Carcinoma of the Head and Neck Trial (OBT076, Balstilimab)
Not yet recruiting
- Adenoid Cystic Carcinoma of the Head and Neck
- (no location specified)
Jul 3, 2023
Adenoid Cystic Carcinoma Trial in Heidelberg (Carbon ion irradiation, Bimodal irradiation)
Recruiting
- Adenoid Cystic Carcinoma
- Carbon ion irradiation
- Bimodal irradiation
-
Heidelberg, GermanyUniversity of Heidelberg, Radiooncology, HIT
Oct 31, 2022
Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Adenoid Cystic Carcinoma
- Adenoid Cystic Carcinoma of the Salivary Gland
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Sep 22, 2022
Carcinoma, Adenoid Cystic, Head Neck Cancer Trial in Pavia (simultaneous integrated boost of carbon ions radiation therapy)
Not yet recruiting
- Carcinoma, Adenoid Cystic
- Head and Neck Cancer
- simultaneous integrated boost of carbon ions radiation therapy
-
Pavia, ItalyCNAO
Feb 8, 2023
Adenoid Cystic Carcinoma Trial in Boston (Radiation, Pembrolizumab)
Completed
- Adenoid Cystic Carcinoma
- Radiation
- Pembrolizumab
-
Boston, Massachusetts
- +1 more
Oct 8, 2022
Salivary Gland Cancer Trial in Cincinnati (Amivantamab)
Recruiting
- Salivary Gland Cancer
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Aug 5, 2022
68Ga-FAPI PET/CT, Metastatic Adenoid Cystic Carcinoma Trial in Beijing (68Ga-FAPI)
Recruiting
- 68Ga-FAPI PET/CT
- Metastatic Adenoid Cystic Carcinoma
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Aug 10, 2022
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Houston (AL101, Therapeutic Conventional Surgery)
Recruiting
- Adenoid Cystic Carcinoma
- Metastatic Adenoid Cystic Carcinoma
- AL101
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)
Recruiting
- Adenoid Cystic Carcinoma
- Salivary Gland Cancer
-
Miami, Florida
- +7 more
Oct 26, 2022
Adenoid Cystic Carcinoma Trial in United States (Lenvatinib)
Active, not recruiting
- Adenoid Cystic Carcinoma
-
Basking Ridge, New Jersey
- +5 more
Jun 1, 2022
Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)
Completed
- Recurrent ACC, metastaticACC, Unreaectable ACC
- Axitinib
- Observation
-
Seoul, Korea, Republic ofDepartment of Internal Medicine, Seoul National University Hospi
Mar 26, 2022
Adenoid Cystic Carcinoma Trial in United States (Regorafenib)
Active, not recruiting
- Adenoid Cystic Carcinoma
-
Basking Ridge, New Jersey
- +4 more
Apr 26, 2022
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Boston (Standard of Care, SBRT)
Recruiting
- Adenoid Cystic Carcinoma
- Metastatic Adenoid Cystic Carcinoma
- Standard of Care
- SBRT
-
Boston, Massachusetts
- +1 more
Dec 29, 2021
Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)
Recruiting
- Carcinoma, Adenoid Cystic
- EGFR-TK Inhibitor
-
Qingdao, Shandong, ChinaQingdao central Hospital
Nov 1, 2021
Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Melbourne (TetMYB Vaccine, BGB-A317)
Active, not recruiting
- Colorectal Cancer
- Adenoid Cystic Carcinoma
- TetMYB Vaccine
- BGB-A317
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 16, 2022
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)
Recruiting
- Salivary Gland Cancer
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 27, 2022
Adenoid Cystic Carcinomas, Cisplatin Trial in Shanghai (Chidamide combined with cisplatin)
Completed
- Adenoid Cystic Carcinomas
- Cisplatin
- Chidamide combined with cisplatin
-
Shanghai, Shanghai, ChinaKai Xue
Aug 18, 2021
Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)
Withdrawn
- Salivary Gland Carcinoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Feb 5, 2022
Adenoid Cystic Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)
Recruiting
- Adenoid Cystic Carcinoma
- 68Ga-PSMA
- 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 18, 2021
Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)
Recruiting
- Salivary Gland Cancer
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 15, 2021